12 completed. 7 Phase 2, 3 Not applicable, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
| Not applicable | 3 | Completed 3 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Sugar Pill (Placebo): new trials by email Literature Review of Sugar Pill (Placebo) trials Research Report on Sugar Pill (Placebo)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Creatine Monohydrate for Mild Traumatic Brain Injury: a Randomised Controlled Pilot Study Creatine Monohydrate, Sugar Pill (Placebo) - Mild Traumatic Brain Injury, Concussion (Diagnosis) | Not applicable | Completed | University of Southern Denmark | 34 | 2023-08-01 | 2026-04-07 |
| Effects of a Thermogenic Dietary Supplement on Metabolic, Hemodynamic, and Mood Responses Sugar Pill (placebo), Caffeine (plus Teacrine and Cayenne), Caffeine (plus Teacrine) - Energy Metabolism, Heart Rate | Not applicable | Completed | University of Mary Hardin-Baylor | 14 | 2018-07-23 | 2019-03-28 |
| Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy Methotrexate, Sugar pill (placebo) - Pediatric Crohn's Disease | Phase 3 | Completed | University of North Carolina, Chapel Hill | 306 | 2016-10-01 | 2023-04-12 |
| Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes Tauroursodeoxycholic Acid (TUDCA), Sugar Pill (placebo) - Type 1 Diabetes | Phase 2 | Completed | Robin Goland, MD | 20 | 2015-08-01 | 2025-06-05 |
| The Effect Methylphenidate Hydrochloride on Pain and Auditory Sensitivity in Healthy Subjects methylphenidate hydrochloride, Sugar pill (placebo) - Pharmacological Action (PA) | Phase 2 | Completed | Rambam Health Care Campus | 41 | 2013-07-01 | 2017-09-12 |
| Statin Therapy in Young Adult Survivors of Childhood Cancer Atorvastatin, Sugar Pill (Placebo) - Cardiovascular Disease, Childhood ALL | Phase 2 | Completed | University of Minnesota | 27 | 2012-11-01 | 2016-12-14 |
| Impact of Probiotics for Reducing Infections in Veterans: The IMPROVE Study Lactobacillus rhamnosus HN001, sugar pill (placebo) - Anti-biotic Resistance | Phase 2 | Completed | VA Office of Research and Development | 113 | 2011-10-01 | 2018-08-03 |
| A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE) Lactobacillus rhamnosus, Sugar pill (placebo) - Infection | Phase 2 | Completed | University of Wisconsin, Madison | 49 | 2010-01-01 | 2015-10-05 |
| A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRE VSL#3, sugar pill (placebo) - Anti-biotic Resistance | Phase 2 | Completed | University of Wisconsin, Madison | 90 | 2008-10-01 | 2015-10-08 |
| A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain zonisamide, olanzapine, Zonisamide - Weight Gain | Phase 3 | Completed | Lindner Center of HOPE | 42 | 2008-01-01 | 2012-04-13 |
| Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones Cystone, Sugar Pill (Placebo) - Cystinuria, Nephrolithiasis, Calcium Oxalate | Phase 1 / Phase 2 | Completed | Mayo Clinic | 20 | 2006-04-01 | 2016-02-04 |
| Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's Disease Donepezil, Sugar Pill (placebo) - Parkinson's Disease | Not applicable | Completed | Oregon Health and Science University | 23 | 2005-10-01 | 2018-05-08 |
Infections (3) · Bipolar Disorder (1) · Brain Concussion (1) · Cardiovascular Diseases (1) · Cystinuria (1) · Diabetes Mellitus, Type 1 (1) · Disease (1) · Ichthyosis prematurity syndrome (1) · Kidney Calculi (1) · Nephrolithiasis (1) · Nephrolithiasis, Calcium Oxalate (1) · Parkinson Disease (1) · Pediatric Crohn's disease (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Psychotic Disorders (1)
University of Wisconsin, Madison (2) · Lindner Center of HOPE (1) · Mayo Clinic (1) · Oregon Health and Science University (1) · Rambam Health Care Campus (1) · Robin Goland, MD (1) · University of Mary Hardin-Baylor (1) · University of Minnesota (1) · University of North Carolina, Chapel Hill (1) · University of Southern Denmark (1) · VA Office of Research and Development (1)
United States (9) · Denmark (1) · Israel (1)
Aaron S Kelly, Ph.D. (1) · Elon Eisenberg, MD (1) · Kathryn Chung, MD (1) · Lemuel W Taylor IV, PhD (1) · Michael D Kappelman, MD (1) · Michael Marcussen, Associate Professor (1) · Nasia Safdar, MD PhD (1) · Nasia Safdar, MD, MS (1) · Nasia Safdar, MD, Ph.D (1) · Robin Goland, MD (1) · Rudolph Leibel, MD (1) · Stephen B. Erickson, M.D. (1) · Susan McElroy, MD (1)
PMID 21161651, PMID 21419606, PMID 22367654, PMID 27836508, PMID 28853979, PMID 29540160, PMID 34547326, PMID 37004887
P50DK083007 (1), U19AR069525 (1)